91Ӱ

Award

Elucidating how chemotherapy induces neurotoxicity

Andre Nussenzweig receives the Bert and Natalie Vallee Award
Andrea Lius
Dec. 2, 2024

As a child, Andre Nussenzweig did everything he could to avoid going into science. Both his parents were scientists, and so were many of his relatives. He really wanted to do something different, and his favorite activity was basketball.

“I’m still obsessed with the sports,” Nussenzweig said. “But then I realized that becoming a professional basketball player wasn’t in the cards, so I should find something else.”

Andre Nussenzweig
Andre Nussenzweig

Nussenzweig explored philosophy, business and the social sciences before deciding to major in physics in college. He trained as a physicist in his Ph.D. program at Yale, and then in his first postdoctoral fellowship in Paris.

“Science is more me,” he said. “But it still has a competitive edge, so in a way there are some interesting parallels with sports.”

Nussenzweig said he found it challenging to make advances in physics because so much was already known. In biology, however, scientists’ predictions often don’t come true. And while unexpected results are sometimes disappointing, they make room for new discoveries.

“Physics didn’t have the same excitement that I saw in biology,” he said.

At first, Nussenzweig considered switching to structural biology. Many physicists who wanted to transition into biology chose this path, he said, because there are some overlaps between the two.

But, the plan didn’t end up working for him. He started taking courses in molecular biology and really enjoyed it. So, he did another postdoctoral fellowship at Memorial Sloan–Kettering Cancer Center for some hands-on experience, then joined the National Institutes of Health in 1998 where he started his own lab.

“The key thing is to be really honest with yourself, see what you enjoy and be fearless about pursuing it, whatever it is,” Nussenzweig said.

“Even if your background and your training aren’t great fits for the role,” he added. “Because you’ll just learn it as you go.”

Nussenzweig will receive the 2025 Bert and Natalie Vallee Award in Biomedical Science, which the 91Ӱ and Molecular Biology presents to an established scientist for outstanding accomplishments in basic biomedical research. His lab studies how DNA damage arises in cancer, as well as in noncancerous, nondividing cells such as neurons.

A detour from heat-shock to DNA repair

Andre Nussenzweig stumbled on the study of DNA damage and repair serendipitously during his postdoc at Sloan-Kettering when his team was working on a project they thought was related to heat-shock proteins. Nussenzweig had generated a knockout mouse for a protein he believed was implicated in the heat-shock response.

“It turned out that gene had nothing to do with heat-shock,” he said. “Instead, it was involved in DNA repair.”

 

Nussenzweig also studies chemotherapies, which purposely induce DNA damage. Specifically, his lab has been looking into the neurotoxic side effects. Although chemotherapy is constantly improving, he said, patients often end up with persistent neurological symptoms and cognitive impairment. Nussenzweig’s team is interested in understanding how different kinds of chemotherapy cause neuron loss or toxicity and how to prevent it.

 

“This is a really big problem in the field,” he said, “and not many people have worked on understanding mechanisms by which chemotherapy induces neurotoxicity.”

 

Andre Nussenzweig will present a talk titled “Maintaining genome stability” at the 2025 91ӰAnnual Meeting, April 12–15 in Chicago.

 

91Ӱ2025 award winners

Read profiles of all the society’s 2025 honorees who will receive their awards and give talks at the 91ӰAnnual Meeting, April 12–15 in Chicago.

From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger receives the 91ӰHerbert Tabor Research Award.

Computational and biophysical approaches to disordered proteins
Rohit Pappu receives the DeLano Award for Computational Biosciences.

Leading the charge for gender equity
Nicole Woitowich receives the 91ӰEmerging Leadership Award.

Helping underrepresented scientists feel seen
Benjamin Garcia receives the 91ӰRuth Kirschstein Diversity in Science Award.

Transforming learning through innovation and collaboration
Neena Grover receives the William C. Rose Award for Exemplary Contributions to Education.

Curiosity turned a dietitian into a lipid scientist
Judy Storch receives the Avanti Award in Lipids.

Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig receives the Bert and Natalie Vallee Award.

What seems dead may not be dead
Vincent Tagliabracci receives the Earl and Thressa Stadtman Distinguished Scientist Award.

'You can't afford to be 15 years behind the parasite'
David Fidock receives the Alice and C.C. Wang Award in Molecular Parasitology.

Guiding grocery carts to shape healthy habits
Robert Helsley receives the Walter A. Shaw Young Investigator in Lipid Research Award.

Enjoy reading 91ӰToday?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Andrea Lius

Andrea Lius is a Ph.D. candidate in the Ong quantitative biology lab at the University of Washington. She is an 91ӰToday volunteer contributor.

Get the latest from 91ӰToday

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

91Ӱmembers recognized as Allen investigators
Member News

91Ӱmembers recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, 91Ӱeducators say
Advice

AI can be an asset, 91Ӱeducators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

91Ӱundergraduate education programs foster tomorrow’s scientific minds
Feature

91Ӱundergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.